Five Alarm Bio to develop drug treatment not to cure ageing but improve healthy lifespan
Cambridge Independent - 04-Nov-2022The company aims at treatments for a range of diseases associated with ageing and disabilities
Join the club for FREE to access the whole archive and other member benefits.
Chief Executive Officer at Five Alarm Bio Limited
Dr Thomas has a background in Biochemistry research at Leicester, Cambridge, and Glaxo, after which she has had 25years of pharmaceutical drug discovery and development experience from large Pharma (GSK) and SME’s. She has been instrumental in the early strategy and growth of small companies including Horizon Discovery (now a public company). She was Director of International Operations at Atlantic Healthcare until she founded Pellis Care Ltd. As a member of leadership teams, Janette has broad experience in developing company and product R&D strategy. Examples of her expertise include the successful completion of commercial-scale oligonucleotide manufacturing process, submission of regulatory dossiers, and invention and grant of patents. She has managed multinational projects for charities and not-for-profits to find new treatments for Malaria and led InnovateUK grants through to successful completion.
Visit website: http://www.fivealarmbio.com/pdfs/PR-FAB-NewCEO.pdf
See also: Five Alarm Bio - Company that develops drugs to slow down the ageing process
Details last updated 08-Nov-2022
The company aims at treatments for a range of diseases associated with ageing and disabilities